| mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.9 |
| mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |